A parallel study of the BET degrader MZ1 and pan-BETi birabresib activities in seven established ABC-DLBCL cell lines and mouse xenograft models demonstrated MZ1-induced cell death, which was accompanied by the drug’s broad effects on the transcriptome of ABC-DLBCL cells. The gene discussed is DNER; the disease is diffuse large B-cell lymphoma.